The agenda is now available for Select Conferences inaugural Ion Channel Targets conference and exhibition being held in Waltham, Boston, 20-21 September 2005. With easy worldwide access and inexpensive registration fees a high degree of interest is anticipated. Early registration is therefore recommended as delegate numbers will be limited.

Attending such events is highly recommended. It lets you increase your knowledge about the agenda of discussion. These platforms are also a great way to build on your network. One such conference got me aware about Recardiowhich helped in curing my cardiovascular health. I also got to encounter new suppliers and vendors here which gave my business a big boost.

We are delighted to announce a top quality agenda featuring 4 sessions and 20 speakers assembled from academia and industry. Chairing the first session, Ion Channels in Drug Discovery, is Dr. Michael Xie who is currently Associated Director of Biology at Synta Pharmaceuticals. On the afternoon of the first day Dr. Chris Mathes, Vice-President and General Manager of Sophion, will chair Advances in Ion Channel Technology and Screening. The second day will open with Ion Channels in Disease Biology chaired by our key note speaker Prof. David Clapham. He is currently Professor of Cardiovascular Research Investigator at the Howard Hughes Medical Institute and Professor of Neurobiology, Harvard Medical School. The meeting will close with Target Identification and Validation chaired by Dr. Maria Garcia, who is a Distinguished Senior Investigator in the Department of Ion Channels at Merck Research Laboratories.

In order to ensure the widest possible audience for our speakers registration fees start at just $399. So, if you want to see the latest research and equipment in ion channels whilst networking with your peers then this event is both affordable and unmissable.

Agenda

Day One 20th September

09:00 Ion Channels in Drug Discovery
Chaired by Dr. Michael Xie – Synta Pharmaceuticals

09:05 Combination Screening of Ion Channel Targets to Reduce False Positive Rate
Dr. Christopher Fanger, Hydra Biosciences

09:40 Ion Channel Targets in Drug Design for Cancer Therapeutics
Dr. Amit Banerjee, Wayne State University

10:15 Coffee and Networking in Exhibition

10:45 Novel Antagonists of Human Kv4.3: HT Ion Channel Screening in Transgenic C. elegans.
Dr. Andreas Kopke, Devgen nv

11:20 HERG, Repolarization and Sudden Cardiac Death
Dr. Arthur M. Brown, ChanTest, Inc.

11:55 Ion Channel Drug Discovery in Non-excitable Cells
Dr. Michael Xie, Synta Pharmaceuticals

12:30 Lunch and Networking in Exhibition

13:45 Advances in Ion Channel Technology and Screening
Chaired by Dr. Chris Mathes – Sophion Biosciences

13:50 Automated Patch Clamp Technology: Evaluation of QPatch® for Voltage Gated Na-channel Characterization
Dr. Mads Peder Gersdorff Korsgaard – Neurosearch

14:25 Utilising Ion Channel Cell Lines and High Throughput Electrophysiology in the Context of Drug Discovery and Development
Dr. Ray Helliwell, Cytomyx

15:00 Application of the Aequorin Assay Technology for Ion Channel Drug Discovery
Dr. Sandra Arpino, GlaxoSmithKline

15:35 Coffee and Networking in Exhibition

16:05 Cell Volume Cytometry

Read More →
Share: